chr16-53622350-C-CGA
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_015272.5(RPGRIP1L):c.3300_3301insTC(p.Ala1101SerfsTer34) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000236 in 593,638 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. L1100L) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_015272.5 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RPGRIP1L | NM_015272.5 | c.3300_3301insTC | p.Ala1101SerfsTer34 | frameshift_variant | 23/27 | ENST00000647211.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RPGRIP1L | ENST00000647211.2 | c.3300_3301insTC | p.Ala1101SerfsTer34 | frameshift_variant | 23/27 | NM_015272.5 |
Frequencies
GnomAD3 genomes AF: 0.0000607 AC: 9AN: 148374Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000274 AC: 2AN: 73014Hom.: 0 AF XY: 0.0000493 AC XY: 2AN XY: 40562
GnomAD4 exome AF: 0.0000112 AC: 5AN: 445172Hom.: 0 Cov.: 0 AF XY: 0.0000168 AC XY: 4AN XY: 237502
GnomAD4 genome AF: 0.0000606 AC: 9AN: 148466Hom.: 0 Cov.: 30 AF XY: 0.0000416 AC XY: 3AN XY: 72164
ClinVar
Submissions by phenotype
Meckel-Gruber syndrome;C0431399:Familial aplasia of the vermis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 27, 2024 | This sequence change creates a premature translational stop signal (p.Ala1101Serfs*34) in the RPGRIP1L gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RPGRIP1L are known to be pathogenic (PMID: 17558409). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with RPGRIP1L-related conditions. ClinVar contains an entry for this variant (Variation ID: 208609). For these reasons, this variant has been classified as Pathogenic. - |
RPGRIP1L-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 24, 2023 | The RPGRIP1L c.3299_3300dupTC variant is predicted to result in a frameshift and premature protein termination (p.Ala1101Serfs*34). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.047% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/16-53656262-C-CGA); however, allele frequency estimates may not be reliable due to poor data quality at this position. Frameshift variants in RPGRIP1L are expected to be pathogenic. This variant is interpreted as likely pathogenic. - |
Joubert syndrome 7 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 30, 2015 | The p.Ala1101SerfsX34 variant in RPGRIP1L has not been previously reported in individuals with RPGRIP1L-related disorders and data from large population studies is insufficient to assess the frequency of this variant. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 1101 and leads to a premature termination codon 34 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Complete loss of RPGRIP1L function is an established disease mechanism in RPGRIP1L-related disorders such as Joubert syndrome and Meckel syndrome (Delous 2007). Moreover, Rpgrip1l -/- mice show a similar phenotype to individuals affected with these disorders including polydactyly, craniofacial malformations, and left-right symmetry defects (Vierkotten 2007). In summary, although additional studies are required to fully establish its clinical significance, the p.Ala1101SerfsX34 variant is likely pathogenic. - |
Meckel syndrome, type 5;C1969053:Joubert syndrome 7;C5436841:COACH syndrome 3 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 16, 2021 | - - |
Joubert syndrome and related disorders Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 10, 2022 | Variant summary: RPGRIP1L c.3299_3300dupTC (p.Ala1101SerfsX34) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been cited in ClinVar and HGMD as pathogenic and disease-associated. The variant allele was found at a frequency of 2.7e-05 in 73014 control chromosomes (gnomAD). To our knowledge, no occurrence of c.3299_3300dupTC in individuals affected with Joubert Syndrome And Related Disorders and no experimental evidence demonstrating its impact on protein function have been reported. Three ClinVar submitters (evaluation after 2014) cite the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at